Fibroblasts of patients affected by Down's syndrome oversecrete amyloid precursor protein and are hyporesponsive to protein kinase C stimulation

Neurology

Volumn 47, Issue 4, 1996, Pages 1069-1075

  Govoni, S ^a,b   Bergamaschi, S ^b   Gasparini, L ^b   Quaglia, C ^b   Racchi, M ^b,c   Cattaneo, E ^b   Binetti, G ^c   Bianchetti, A ^c   Giovetti, F ^d   Battaini, F ^e   Trabucchi, M ^e  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Alzheimer's Department   (Italy)

^d Hospital Institute of Sospiro   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PHORBOL DIBUTYRATE; PROTEIN KINASE C;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DOSE RESPONSE; DOWN SYNDROME; ENZYME ACTIVATION; FEMALE; GENE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN SECRETION; QUANTITATIVE DIAGNOSIS; TRISOMY 21;

EID: 10244263597     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.4.1069     Document Type: Article

References (43)

1. Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 1985;17:278-282.
2. Oliver C, Holland AJ. Down's syndrome and Alzheimer's disease: a review. Psychol Med 1986;16:307-322.
3. Brugge KL, Nichols SL, Salmon DP, et al. Cognitive impairment in adults with Down's syndrome: similarities to early cognitive changes in Alzheimer's disease. Neurology 1994;44: 232-238.
4. Holland AJ, Oliver C. Down's syndrome and the links with Alzheimer's disease. J Neurol Neurosurg Psychiatry 1995;59: 111-114.
5. Kesslak JP, Nagata SF, Lott I, Nalcioglu O. Magnetic resonance imaging analysis of age-related changes in the brains of individuals with Down's syndrome. Neurology 1994;44:1039-1045.
6. Schapiro MB, Haxby JV, Grady CL. Nature of mental retardation and dementia in Down syndrome: study with PET, CT, and neuropsychology. Neurobiol Aging 1992;13:723-734.
7. Godridge H, Reynolds GP, Czudek C, Calcutt NA, Benton M. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue. J Neurol Neurosurg Psychiatry 1987;50: 775-778.
8. Reynolds GP, Warner EJ. Amino acid transmitter deficits in adult Down's syndrome brain tissue. Neurosci Lett 1988;94: 224-227.
9. Beyreuther K, Pollwein P, Multhaup G, et al. Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease and Down's syndrome. Ann NY Acad Sci 1993;695:91-102.
10. Oyama F, Cairns NJ, Shimada H, Oyama R, Titani K, Ihara Y. Down's syndrome: up-regulation of β-amyloid protein precursor and its mRNAs and their defective coordination. J Neurochem 1994;62:1062-1066.
11. Goldgaber D, Lerman MI, McBride WO, Saffiotti U, Gajdusek CD. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 1987; 235:877-880.
12. Selkoe DJ. Normal and abnormal biology of the β-amyloid precursor protein. Annu Rev Neurosci 1994;17:489-517.
13. Armstrong RA, Differences in β-amyloid (β/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease. Neurosci Lett 1994;169:133-136.
14. Wisniewski T, Ghiso J, Frangione B. Alzheimer's disease and soluble Aβ. Neurobiol Aging 1994;15:143-152.
15. Kametani F, Tanaka K, Tokuda T, Ikeda S. Secretory cleavage site of Alzheimer amyloid precursor protein is heterogeneous in Down's syndrome brain. FEBS Lett 1994;351:165-167.
16. Kida E, Wisniewski KE, Wisniewski HM. Early amyloid-β deposits show different immunoreactivity to the amino- and carboxy-terminal regions of β-peptide in Alzheimer's disease and Down's syndrome brain. Neurosci Lett 1995;193:105-108.
17. Blass JP, Baker AC, Sheu K-FR, Ko L, Black RS, Smith A. Use of cultured skin fibroblasts in studies of Alzheimer's disease. In: Boller F, Katzman R, Rascol A, Signoret JL, Christen Y, eds. Biological markers of Alzheimer's disease. New York: Springer Verlag, 1989:153-162.
18. Blass JP. The cultured fibroblast model. J Neural Transm 1994;44(suppl):87-95.
19. Wen GY, Wisniewski HM, Blondal H, et al. Presence of nonfibrillar amyloid beta protein in skin biopsies of Alzheimer's disease (AD), Down's syndrome and non-AD normal persons. Acta Neuropathol (Berl) 1994;88:201-206.
20. Rumble B, Retallack R, Hilbich C, et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 1989;320:1446-1452.
21. Bergamaschi S, Binetti G, Govoni S, et al. Defective phorbol ester-stimulated secretion of β-amyloid precursor protein from Alzheimer's disease fibroblasts. Neurosci Lett 1995;201:l-4.
22. Citron M, Vigo-Pelfrey C, Teplow DB, et al. Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer's disease mutation. Proc Natl Acad Sci USA 1994; 91:11993-11997.
23. Querfurth HW, Wijsman EM, St. George-Hyslop PH, Selkoe DJ. βAPP mRNA transcription is increased in cultured fibroblasts from the familial Alzheimer's disease-1 family. Mol Brain Res 1995;28:319-337.
24. Bergamaschi S, Quaglia C, Racchi M, et al. Altered protein kinase C-stimulated β-amyloid protein precursor secretion from fibroblasts of patients with Down's syndrome [abstract]. Neurology 1995;45(suppl 4):A307.
25. Evenhuis H. The natural history of dementia in Down's syndrome. Arch Neurol 1990;47:263-267.
26. Folstein MF, Folstein SE, McHugh PR. Mini Mental State. J Psychiatr Res 1975;12:189-198.
27. Orsini A, Grossi D, Capitani E, Laiacona M, Papagno C, Vallar G. Verbal and spatial immediate memory span: normative data from 1,355 adults and 1,112 children. Ital J Neurol Sci 1987;8:539-548.
28. Novelli G, Papagno C, Capitani E, Laiacona M, Vallar G, Cappa SF. Tre test clinici di ricerca e profusione lessicale. Taratura su soggetti normali. Arch Psicol Neurol Psichiat 1986;4:477-506.
29. De Renzi E, Vignolo LA. The token test: a sensitive test to detect receptive disturbances in aphasia. Brain 1962;85:665-678.
30. Lowton MP, Brody EM. Assessment of older people: self maintaining and Instrumental Activities of Daily Living. Gerontologist 1969;9:176-186.
31. Katz S, Downs TD. Progress in development of the index of ADL. Gerontologist 1970;10:20-30.
32. Govoni S, Bergamaschi S, Racchi M, et al. Cytosol protein kinase C downregulation in fibroblasts from Alzheimer's disease patients. Neurology 1993;43:2581-2586.
33. Carmeliet G, Hauman R, Dom R, et al. Growth properties and in vitro life span of Alzheimer disease and Down syndrome fibroblasts: a blind study. Mech Ageing Dev 1990;53:17-33.
34. Carmeliet G, David G, Cassiman J-J. Cellular ageing of Alzheimer's disease and Down syndrome cells in culture. Mutat Res 1991;256:221-231.
35. Henriksson T, Barbour RM, Braa S, et al. Analysis and quantification of the β-amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients with a monoclonal antibody-based immunoassay. J Neurochem 1991;56:1037-1042.
36. Racchi M, Bergamaschi S, Govoni S, et al. Characterization and distribution of protein kinase C isoforms in human skin fibroblasts. Arch Biochem Biophys 1994;314:107-111.
37. Loffler J, Huber G. Modulation of β-amyloid precursor protein secretion in differentiated and nondifferentiated cells. Biochem Biophys Res Commun 1993;195:97-103.
38. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227: 680-685.
39. Giaccone C, Tagliavini F, Linoli G, et al. Down patients: extra-cellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci Lett 1989;97:232-238.
40. Masters CL, Simms G, Weinmann NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc Natl Acad Sci USA 1985;82:4245-4249.
41. Motte J, Williams RS. Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down's syndrome brains. Acta Neuropathol (Berl) 1989;77:535-546.
42. Racchi M, Wetsel WC, Trabucchi M, et al. Reduced protein kinase C immunoreactivity in fibroblasts from patients with Alzheimer's disease [abstract]. Neurology 1994;44(suppl 2): A164.
43. Van Gool WA, Evenhuis HM, Van Duijn CM, on Behalf of the Dutch Study Group on Down's Syndrome and Ageing. A casecontrol study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Ann Neurol 1995; 38:225-230.